stocktrader

Lockheed Martin (NYSE: LMT), a titan in the defense and aerospace sector, is back in the spotlight after experiencing seven consecutive days of gains. This surge follows the company’s recent Q2 earnings report, but the reasons behind this rally go beyond a single quarterly update. As geopolitical tensions simmer globally, Lockheed Martin’s stock is reflecting… Continue reading Lockheed Martin’s stock soars: What’s behind the 7-day rally?

Riot Platforms (RIOT) stock price has broken a bad record for the year. It has retreated in the past nine straight days and reached a low of $10, its lowest swing since July 12. It was its longest losing streak since January when it tumbled for six days straight.  Bitcoin price retreat continues Riot Platforms,… Continue reading Riot Platforms stock has a 71% upside: analyst

UK stocks are poised for potential gains following the Bank of England’s (BOE) decision to cut the key interest rate by 25 basis points to 5.0%.  This move, aimed at stimulating economic growth, aligns with historical trends that suggest a positive outlook for benchmark UK indices in the months ahead. Historical performance of FTSE 100… Continue reading How have UK stocks historically performed after BOE rate cuts?

Deutsche Bank upgraded Corning Inc. (NYSE: GLW) to a Buy from Hold, with a new price target of $46, on July 31, 2024. This revision comes in the wake of Corning’s Q2 earnings report released a day prior. Analysts’ views Deutsche Bank’s optimism is pinned on the projected double-digit EPS growth over the next few… Continue reading Deutsche Bank thinks Corning’s stock can reach $46: Should you buy?

Vaccinex Inc (NASDAQ: VCNX) tanked an alarming 40% on Wednesday despite it reporting positive early-stage results for its Alzheimer’s treatment.  The biotechnology company said its SIGNAL-AD trial established its pepinemab antibody as well-tolerated by patients of AD. A total of 16 clinical sites participated in the study, none of which reported any treatment-related serious adverse… Continue reading Vaccinex stock tanks 40% despite positive Alzheimer’s study update

Mastercard (NYSE:MA) just announced its Q2 earnings and the stock is up 4% during trading hours today. The company posted a beat on both revenue and EPS as consumers continued spending during the quarter. Double-digit growth of both the top line and bottom line comes as a relief to investors who were worried about the… Continue reading Mastercard jumps after Q2 earnings, is ’embedded finance’ the future?

Mobileye Global Inc. (NASDAQ: MBLY) faces a pivotal moment as it heads into its Q2 earnings report, set for tomorrow. Already under pressure with a 54% drop in its stock value year-to-date, the company’s challenges were compounded today as J.P. Morgan downgraded the stock. Citing concerns about the SuperVision product and inventory issues, analyst Samik… Continue reading J.P. Morgan downgrades Mobileye Global ahead of Q2 earnings: Will the stock keep falling?

Uber Technologies Inc. has announced a significant expansion of its electric vehicle (EV) fleet, with plans to introduce around 100,000 EVs manufactured by Chinese automaker BYD Co. Ltd. The initiative will initially focus on Europe and Latin America, with future expansions planned for the Middle East, Canada, Australia, and New Zealand. The collaboration aims to… Continue reading Uber to integrate 100,000 BYD electric vehicles in Europe and Latin America

Microsoft just announced its Q4 earnings and the stock hasn’t responded well. The stock fell as much as 7% after the announcement, though most of it has been recovered as we head into today’s trading session. The reason for the downfall was a slowdown in the growth of the cloud segment. This in itself wouldn’t… Continue reading Microsoft’s loss, Nvidia’s gain: Should investors worry about ever-increasing AI spending?